Planning
Thursday, October 2, 2014
| Time |
Event |
|
|
09:00 - 13:15
|
INTRODUCTORY PRESENTATIONS |
|
|
09:00 - 09:45
|
Pharmacokinetics and pharmacodynamic concepts - Tobias Paehler (Sanofi, Germany) |
|
|
09:45 - 10:30
|
Computational approaches for prediction/simulation of drug delivery - Tarek Mounir (University of Nancy, France) |
|
|
10:30 - 11:00
|
Coffee break |
|
|
11:00 - 11:45
|
In vitro/in vivo correlation: a biopharmaceutics tool used in drug development - Jean-michel Cardot, (University Clermont-Ferrand, France) |
|
|
11:45 - 12:30
|
Principles of Electroporation for drug delivery - Marie-Pierre Rols (University of Toulouse, France) |
|
|
12:30 - 13:15
|
Electroporation : characterization, tools, and constraints for in vivo delivery - Damijan Miklavcic (University of Ljubljana, Slovenia) |
|
|
13:15 - 14:30
|
Lunch break and Networking |
|
|
14:30 - 17:15
|
ORAL ROUTE |
|
|
14:30 - 15:15
|
Oral Drug Delivery: Physiological challenges for pharmaceutics - Clive Wilson (University of Strathclyde, UK) |
|
|
15:15 - 16:00
|
Computational models for Drug Delivery by Oral Administration. - Michael B. Bolger (Simulations Plus, California, USA) |
|
|
16:00 - 16:30
|
Coffee break |
|
|
16:30 - 17:15
|
In vitro models for assessment of oral drug absorption - Per Artursson (Uppsala University, Sweden) |
|
|
17:15 - 18:30
|
TBA - Short oral communications |
|
| Time |
Event |
|
|
09:00 - 13:15
|
PARENTERAL ROUTE 1: Intravenous (models/tools for drug delivery to cancer and to brain) |
|
|
09:00 - 09:45
|
Physiological barriers to drug delivery by i.v. route, clinical relevance, and challenges) - Jean-Marie Devoisselle (University of Montpellier, France) |
|
|
09:45 - 10:30
|
In vitro and in vivo models for drug delivery to cancer - Khaled Greish (University Otago, New Zealand) |
|
|
10:30 - 11:00
|
Coffee break |
|
|
11:00 - 11:45
|
Preclinical development of electrochemotherapy (ECT) for treatment of tumors. - Gregor Sersa (Institute of Oncology Ljubljana, Slovenia) |
|
|
11:45 - 12:30
|
Targeting the blood brain barrier to improve drug delivery to brain - Xavier Descleves, (University Paris Descartes, Paris, France) |
|
|
12:30 - 13:15
|
Challenges of using In vitro data for modeling P-glycoprotein efflux in the blood-brain barrier - Marjo Yliperttula (University of Helsinki, Finland) |
|
|
13:15 - 14:30
|
Lunch break and networking |
|
|
14:30 - 16:30
|
PARENTERAL ROUTE 1: Alternative routes: Pulmonary, Nasal and Cutaneous |
|
|
14:30 - 15:15
|
Drug delivery to the lungs: barriers, challenges and opportunities - Rita Vanbever (University of Louvain, Belgium) |
|
|
15:15 - 15:45
|
Coffee break |
|
|
15:45 - 16:30
|
In vitro models of pulmonary drug disposition - are we there yet? - Carsten Ehrhardt (University of Dublin, Ireland) |
|
|
16:30 - 17:30
|
TBA - Short Oral Communications |
|
Saturday, October 4, 2014
| Time |
Event |
|
|
09:00 - 14:00
|
PARENTERAL ROUTE 1: Alternative routes: Pulmonary, Nasal and Cutaneous |
|
|
09:00 - 09:45
|
Challenges in percutaneous drug delivery: Recent developments in formula and predicting tools - Begoña Delgado-Charro (University of Bath, United Kingdom) |
|
|
09:45 - 10:30
|
DNA electroporation for local delivery of therapeutic proteins and vaccines - Gaelle Vandermeulen (Université Catholique de Louvain, Belgium) |
|
|
10:30 - 11:00
|
Coffee break |
|
|
11:00 - 11:45
|
Current clinical experience on electroporation based treatments, and future prospects - Julie Gehl (Herlev Hospital, Copenhagen, Denmark) |
|
|
11:45 - 12:30
|
Nanomedicine revolution: the path through regulatory science into personalized medicine - Rogerio Gaspar (University of Lisbon, Portugal) |
|
|
